PDCD1 and cancer: CTLA-4 is expressed by T cells and binds to its ligands CD80 or CD86, which are present on professional antigen-presenting cells, while PD-1 is expressed by T cells and many other immune cell types, and its ligand PD-L1 is present on several types of immune cells but also somatic cells and cancer (116–118).